NanoRepro AG (FRA:NN6)

Market Cap	20.18M +5.3%
Revenue (ttm)	4.34M -3.0%
Net Income	-1.99M
EPS	-0.16
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,194
Open	1.600
Previous Close	1.660
Day's Range	1.600 - 1.600
52-Week Range	1.310 - 2.260
Beta	n/a
Analysts	n/a
Price Target	n/a
Est. Earnings	Jun 7, 2027

About NanoRepro AG

NanoRepro AG engages in the development, manufacture, and distribution of rapid diagnostic tests and food supplements for home and professional use in Germany and internationally. The company offers products in the areas of family planning, preventive healthcare, intolerances, and infectious diseases. It also develops and commercializes immunochromatographic lateral flow tests; and point of care testing for hospitals and medical practices. NanoRepro AG was incorporated in 2007 and is headquartered in Marburg, Germany.

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 2007
• Employees: 22
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: NN6

Financial Performance

In 2025, NanoRepro AG's revenue was 4.34 million, a decrease of -3.02% compared to the previous year's 4.47 million. Losses were -1.99 million, -2.87% less than in 2024.

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Oct 26, 2026

Data Sources Report a data error